Brightstar Therapeutics

Developer of therapeutics for corneal and ocular surface diseases

placeLexington, Kentucky, United States calendar_todayFounded 2023 groups4 employees language brightstartx.com

Social engagement

Social engagement: 288 social following, 6 posts in the last 12 months — top 10% of its industry.

Investor mix

3 investors on record; lead investors include Saving-Sight.

Investor typeCountShare
Other / undisclosed3100%

Recent activity

5 Mar 2026
Partnership
Brightstar Therapeutics
19 Jan 2026
Event
Hawaiian Eye Meeting
8 Sep 2025
Event
BrightMEMTM Corneal Allograft Wet Lab
Coming soon